Effect of intravenous immunoglobulin (IVIg) on primate complement-dependent cytotoxicity of genetically engineered pig cells: relevance to clinical xenotransplantation.

Scientific Reports
Takayuki YamamotoHidetaka Hara

Abstract

Triple-knockout (TKO) pigs may be ideal sources of organs for clinical xenotransplantation because many humans have no preformed antibody to TKO pig cells. Intravenous immunoglobulin (IVIg) is widely used for severe infection or the treatment/prevention of antibody-mediated rejection in allotransplantation. Anti-pig antibodies in IVIg could be harmful in clinical xenotransplantation. It is unknown whether anti-TKO pig antibodies are present in IVIg. The main aim of this study was to investigate in vitro whether IVIg contains anti-TKO pig antibodies with cytotoxic effect to pig cells. Undiluted pooled human serum (HS) and five different commercial preparations of IVIg were tested for IgM and IgG binding to red blood cells (RBCs) from wild-type (WT), α1,3-galactosyltransferase gene-knockout (GTKO), and TKO pigs by flow cytometry. Complement-dependent lysis of IVIg against these pig pRBCs was measured by hemolytic assay. Pooled HS and 4 of 5 IVIg commercial preparations contained anti-pig IgG that bound to WT and GTKO pRBCs, but not to TKO pRBCs. One preparation of IVIg contained antibodies that bound to TKO pRBCs, but there was no cytotoxicity of IVIg to TKO pRBCs. The results suggest that IVIg administration to human recipients ...Continue Reading

References

Nov 1, 1995·The Journal of Clinical Investigation·J C MageeJ L Platt
Jul 4, 1998·Scandinavian Journal of Immunology·A E FianeT E Mollnes
Sep 8, 2001·The New England Journal of Medicine·M D Kazatchkine, S V Kaveri
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Thiruma V ArumugamMark P Mattson
Jul 19, 2008·The New England Journal of Medicine·Ashley A VoStanley C Jordan
Sep 4, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Hidetaka HaraDavid K C Cooper
Jun 16, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L KesslerUNKNOWN GRAGIL Study Group
Jul 9, 2009·Transplantation·Stanley C JordanAshley A Vo
Apr 1, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K BächlerS Schaub
Jan 12, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S C JordanA A Vo
Sep 16, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Andrew C IssekutzHeather F Macmillan
May 4, 2015·British Medical Bulletin·Stanley C JordanAshley Vo
Jul 29, 2015·Journal of Leukocyte Biology·Lisa K KozickyLaura M Sly
Sep 15, 2015·The Journal of Pathology·David Kc CooperDavid Ayares
Nov 5, 2015·Current Opinion in Organ Transplantation·Fasika M TedlaAmarpali Brar
Jan 28, 2016·Xenotransplantation·David K C CooperRita Bottino
Mar 19, 2016·Xenotransplantation·Whayoung LeeDavid K C Cooper
Jul 6, 2016·Transplantation·Zheng-Yu WangA Joseph Tector
May 27, 2017·Xenotransplantation·Zhongqiang ZhangHidetaka Hara
Jul 18, 2017·PloS One·Bingsi GaoHidetaka Hara
May 4, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Jaeyoung KimMee Kum Kim
Jul 27, 2018·Annals of Surgery·Andrew B AdamsAlfred Joseph Tector
Dec 7, 2018·Nature·Matthias LänginJan-Michael Abicht

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
gene-knockout
flow cytometry
fluorescence-activated cell sorting
FACS
ELISA

Software Mentioned

GraphPad
GraphPad Prism

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.